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This study examined whether enhancement of the endogenous cannabi-
noid level by local administration of the fatty acid amide hydrolase (FAAH)
inhibitor URB597 into the knee joint could modulate joint nociception and
consequently pain transmission in this animal model of naturally occurring
osteoarthritis in the guinea pigs.
Methods: Guinea pigs (9 months of age) were deeply anaesthetised
with ethyl carbamate (urethane; 2mg×kg−1 i.p.). Joint nociception was
objectively measured in the animals by electrophysiological recordings
from knee joint primary afferents in response to normal rotation and
noxious hyper-rotation of the joint. Rotations were done both before and
after close intra-arterial injection of URB597 (30 ug; 100 ul bolus). The
number of action potentials per movement were determined 1, 3, 5, 7
and 10 minutes after the URB597 injection.
Recording of a typical single knee joint afferent in response to noxious
rotation. Close intra arterial injection of the fatty acid amid hydrolase
inhibitor (FAAH) URB597 reduces ﬁring frequency of the ﬁbre.
Results: A single injection of URB597 caused the afferent ﬁring rate to
be signiﬁcantly reduced during normal rotation and during hyper-rotation
of guinea pig knee joint. The desensetizing effect was maximal 5 minutes
after URB597 application. About 30% of the recorded afferents showed
spontaneous activity, of which URB597 signiﬁcantly reduced the ﬁring rate
in the majority. Blockage of peripheral CB1 receptors by co-administration
of the selective CB1 receptor antagonist AM251 (10−9 mol) abolished the
antinociceptive effect of URB597, conﬁrming that the effect is mediated
via the CB1 receptor.
Recording of a spontaneous active joint afferent. URB597 reduces ﬁring
frequency and subsequently inhibits tonically nociceptive transmission.
Conclusions: The ﬁndings indicate that close intra-arterial injection of
URB597 into the osteoarthritic knee joint of Dunkin Hartley guinea pigs
alleviated peripheral sensitization of knee joint afferents and consequently
reduced pain transmission during joint movement. In addition, a reduction
of spontaneous activity reﬂects a corresponding decrease of tonically
transmitted nociceptive information. The results show that a local increase
of the endocannabinoid level has a direct desensetizing effect on afferent
nerve activity in the guinea pig knee joint, providing new evidence for
the role of the endocannabinoid system in peripheral pain modulation.
Targeting cannabinoid metabolizing enzymes in the peripheral nervous
system could offer novel therapeutic approaches for efﬁcient treatment
of osteoarthritis pain without psychotropic side effects accompanied with
systemic cannabinoid administration.
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Purpose: To examine the association of serum cartilage oligomeric
matrix protein (COMP) and hyaluronan (HA) levels with the estimation
of articular damage and disease progression in patients with knee os-
teoarthritis (OA).
Methods: A total of 134 patients with available sera and evidence of
radiographic knee OA were examined. Biological markers were measured
at baseline, and following 3, 6 and 12 months. COMP was quantiﬁed by
enzyme-linked immunosorbent assay (ELISA) and HA was measured by
inhibition binding assay. Knee anteroposterior radiographs under weight
bearing were obtained at baseline, following 12 and 24 months. OA stage
was assessed by Kellgren and Lawrence grade (K-L grade) and joint
space width (JSW) was also measured. Clinical signs and symptoms
were interviewed and assessed by Lequesne’s index and visual analogue
scale (VAS) score.
Results: COMP did not show signiﬁcant correlation with gender and
obesity. COMP of K-L grade 3 was higher than any other grade, however
there was not any correlation with clinical evaluation. HA was slightly
higher in female and showed signiﬁcant correlation with clinical scores,
however did not show correlation with radiological severity. Baseline and
average COMP levels were higher in the progressive group which showed
radiological joint space narrowing over 1mm in 12 months or 24 months,
than in the non-progressive group which showed narrowing within 1mm
for a following period.
Conclusions: COMP elevation of K-L grade 3 may indicate high turnover
of cartilage metabolism according to OA progression, and its decrease
in grade 4 may reﬂect loss of cartilage amount or low turnover of
cartilage tissue in the most advanced stage. Since there was signiﬁcant
correlation between elevation of serum COMP and joint space narrowing,
COMP could predict rapid OA progression. Correlation of HA with clinical
evaluation suggests that clinical severity of OA could be affected by
synovial inﬂammation rather than cartilage destruction.
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Purpose: To determine relationship between disease activity, systemic
markers of cartilage degradation, urinary C-terminal cross linking telopep-
tides of type II collagen (uCTX-II), and bone degradation, urinary
C-terminal cross linking telopeptides of type I collagen (uCTX-I), structural
progression of osteoarthritis (OA) and potential therapeutic efﬁcacy of
type II collagen in combination with glucosamine and chondroitinsulphate.
Methods: An observational retrospective study, 1 year follow-up, on
104 patients with osteoarthritis (nodular osteoarthritis of the hand, HOA,
erosive osteoarthritis of the hand, EOA, osteoarthritis of the knee or
hip) who were treated with glucosamine and chondroitinsulphate (GC)
or glucosamine, chondroitinsulphate and collagen type II (GCC). The
following information was collected at entry: demographics, BMI, charac-
teristics of OA, patient global assessment (VAS), C-terminal crosslinking
telopeptides of collagen types I (uCTX-I) and II (uCTX-II) and radiographs.
